Structure

Physi-Chem Properties

Molecular Weight:  288.1
Volume:  287.755
LogP:  3.022
LogD:  2.866
LogS:  -3.662
# Rotatable Bonds:  2
TPSA:  79.15
# H-Bond Aceptor:  5
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.74
Synthetic Accessibility Score:  2.623
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.946
MDCK Permeability:  1.4657228348369244e-05
Pgp-inhibitor:  0.009
Pgp-substrate:  0.013
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.021
30% Bioavailability (F30%):  0.006

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.021
Plasma Protein Binding (PPB):  97.03849029541016%
Volume Distribution (VD):  0.547
Pgp-substrate:  3.70833158493042%

ADMET: Metabolism

CYP1A2-inhibitor:  0.86
CYP1A2-substrate:  0.95
CYP2C19-inhibitor:  0.14
CYP2C19-substrate:  0.115
CYP2C9-inhibitor:  0.196
CYP2C9-substrate:  0.866
CYP2D6-inhibitor:  0.302
CYP2D6-substrate:  0.883
CYP3A4-inhibitor:  0.239
CYP3A4-substrate:  0.3

ADMET: Excretion

Clearance (CL):  8.205
Half-life (T1/2):  0.504

ADMET: Toxicity

hERG Blockers:  0.103
Human Hepatotoxicity (H-HT):  0.072
Drug-inuced Liver Injury (DILI):  0.143
AMES Toxicity:  0.641
Rat Oral Acute Toxicity:  0.434
Maximum Recommended Daily Dose:  0.247
Skin Sensitization:  0.774
Carcinogencity:  0.054
Eye Corrosion:  0.004
Eye Irritation:  0.913
Respiratory Toxicity:  0.534

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC212942

Natural Product ID:  NPC212942
Common Name*:   Calanhydroquinone B
IUPAC Name:   5,6-dimethoxy-9,10-dihydrophenanthrene-1,4,7-triol
Synonyms:   Calanhydroquinone B
Standard InCHIKey:  NLKJYEXGUVVXMN-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H16O5/c1-20-15-12(19)7-8-3-4-9-10(17)5-6-11(18)14(9)13(8)16(15)21-2/h5-7,17-19H,3-4H2,1-2H3
SMILES:  COc1c(cc2CCc3c(ccc(c3-c2c1OC)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL562912
PubChem CID:   25243458
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives
        • [CHEMONTID:0000223] Hydrophenanthrenes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13975 Calanthe arisanensis Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[18640035]
NPO13975 Calanthe arisanensis Species Orchidaceae Eukaryota n.a. n.a. n.a. PMID[19193043]
NPO8774 Walsura cochinchinensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[23795939]
NPO13975 Calanthe arisanensis Species Orchidaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO8774 Walsura cochinchinensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5001 Ramalina calicaris Species Ramalinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO5822 Suberites massa Species Suberitidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14623 Senecio clevelandi Species Asteraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens EC50 = 4.07 ug.mL-1 PMID[529662]
NPT306 Cell Line PC-3 Homo sapiens EC50 = 2.62 ug.mL-1 PMID[529662]
NPT90 Cell Line DU-145 Homo sapiens EC50 = 5.46 ug.mL-1 PMID[529662]
NPT180 Cell Line HCT-8 Homo sapiens EC50 = 5.16 ug.mL-1 PMID[529662]
NPT83 Cell Line MCF7 Homo sapiens EC50 = 3.28 ug.mL-1 PMID[529662]
NPT91 Cell Line KB Homo sapiens EC50 = 3.75 ug.mL-1 PMID[529662]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. EC50 = 5.24 ug.mL-1 PMID[529662]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC212942 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC79622
1.0 High Similarity NPC29868
0.9847 High Similarity NPC205442
0.9847 High Similarity NPC202846
0.9847 High Similarity NPC143139
0.9776 High Similarity NPC175838
0.9771 High Similarity NPC108198
0.9771 High Similarity NPC69029
0.9771 High Similarity NPC294884
0.9771 High Similarity NPC158142
0.9771 High Similarity NPC10314
0.9771 High Similarity NPC200557
0.9695 High Similarity NPC125649
0.9695 High Similarity NPC160697
0.9627 High Similarity NPC73505
0.9627 High Similarity NPC165026
0.9627 High Similarity NPC295719
0.9627 High Similarity NPC12668
0.9627 High Similarity NPC308768
0.9627 High Similarity NPC34431
0.9624 High Similarity NPC201145
0.9624 High Similarity NPC272157
0.9624 High Similarity NPC73535
0.9624 High Similarity NPC6262
0.9624 High Similarity NPC242715
0.9624 High Similarity NPC56329
0.9624 High Similarity NPC90615
0.9624 High Similarity NPC25111
0.9621 High Similarity NPC313081
0.9621 High Similarity NPC241241
0.9552 High Similarity NPC243759
0.9552 High Similarity NPC184613
0.9552 High Similarity NPC220344
0.9552 High Similarity NPC243996
0.9552 High Similarity NPC132804
0.9552 High Similarity NPC105847
0.9552 High Similarity NPC275061
0.9552 High Similarity NPC218131
0.9549 High Similarity NPC300846
0.9549 High Similarity NPC114155
0.9549 High Similarity NPC476639
0.9549 High Similarity NPC30632
0.9478 High Similarity NPC151656
0.9478 High Similarity NPC266006
0.9478 High Similarity NPC230919
0.9478 High Similarity NPC22902
0.9478 High Similarity NPC266453
0.9478 High Similarity NPC200935
0.9474 High Similarity NPC283009
0.9474 High Similarity NPC261873
0.9474 High Similarity NPC111655
0.9407 High Similarity NPC114171
0.9407 High Similarity NPC6300
0.9407 High Similarity NPC230124
0.9398 High Similarity NPC103967
0.9398 High Similarity NPC209199
0.9394 High Similarity NPC6451
0.9394 High Similarity NPC161958
0.9394 High Similarity NPC14224
0.9389 High Similarity NPC234488
0.9389 High Similarity NPC126836
0.9389 High Similarity NPC299221
0.9389 High Similarity NPC311680
0.9389 High Similarity NPC51840
0.9343 High Similarity NPC183709
0.9323 High Similarity NPC32778
0.9318 High Similarity NPC232275
0.9318 High Similarity NPC12275
0.9318 High Similarity NPC474356
0.9318 High Similarity NPC45715
0.9313 High Similarity NPC58164
0.9313 High Similarity NPC10225
0.9254 High Similarity NPC289258
0.9254 High Similarity NPC7515
0.9254 High Similarity NPC555
0.9254 High Similarity NPC56764
0.9254 High Similarity NPC206737
0.9254 High Similarity NPC188378
0.9254 High Similarity NPC276026
0.9254 High Similarity NPC469659
0.9248 High Similarity NPC218884
0.9242 High Similarity NPC224157
0.9242 High Similarity NPC192687
0.9237 High Similarity NPC266691
0.9237 High Similarity NPC154866
0.9214 High Similarity NPC112251
0.9209 High Similarity NPC50250
0.9185 High Similarity NPC214853
0.9185 High Similarity NPC240279
0.9185 High Similarity NPC180602
0.9185 High Similarity NPC256262
0.9185 High Similarity NPC55239
0.9173 High Similarity NPC15543
0.9167 High Similarity NPC190144
0.916 High Similarity NPC124452
0.916 High Similarity NPC82679
0.916 High Similarity NPC159968
0.916 High Similarity NPC236791
0.916 High Similarity NPC471986
0.916 High Similarity NPC324112
0.916 High Similarity NPC169474
0.916 High Similarity NPC266555
0.916 High Similarity NPC74817
0.916 High Similarity NPC293054
0.916 High Similarity NPC246620
0.916 High Similarity NPC282000
0.9149 High Similarity NPC262297
0.9137 High Similarity NPC469630
0.913 High Similarity NPC472089
0.9124 High Similarity NPC127218
0.9124 High Similarity NPC319647
0.9124 High Similarity NPC245207
0.9124 High Similarity NPC25966
0.9118 High Similarity NPC133025
0.9111 High Similarity NPC311256
0.9104 High Similarity NPC228843
0.9091 High Similarity NPC28765
0.9084 High Similarity NPC214406
0.9084 High Similarity NPC44748
0.9084 High Similarity NPC78974
0.9084 High Similarity NPC223953
0.9084 High Similarity NPC223136
0.9084 High Similarity NPC28730
0.9084 High Similarity NPC170485
0.9084 High Similarity NPC103823
0.9084 High Similarity NPC18924
0.9078 High Similarity NPC33832
0.9078 High Similarity NPC126291
0.9065 High Similarity NPC191231
0.9065 High Similarity NPC472088
0.9065 High Similarity NPC472087
0.9065 High Similarity NPC470917
0.9058 High Similarity NPC472091
0.9058 High Similarity NPC472092
0.9058 High Similarity NPC259519
0.9058 High Similarity NPC472090
0.9051 High Similarity NPC86605
0.9051 High Similarity NPC46277
0.9051 High Similarity NPC156948
0.9051 High Similarity NPC107551
0.9051 High Similarity NPC276490
0.9051 High Similarity NPC474282
0.9051 High Similarity NPC326797
0.9051 High Similarity NPC301765
0.9051 High Similarity NPC102904
0.9051 High Similarity NPC3072
0.9051 High Similarity NPC176051
0.9051 High Similarity NPC103976
0.903 High Similarity NPC149337
0.903 High Similarity NPC471983
0.9015 High Similarity NPC21563
0.9015 High Similarity NPC252131
0.9015 High Similarity NPC127587
0.9015 High Similarity NPC236760
0.9008 High Similarity NPC472093
0.9008 High Similarity NPC208950
0.9008 High Similarity NPC299584
0.9008 High Similarity NPC57490
0.9008 High Similarity NPC265483
0.9008 High Similarity NPC116907
0.9008 High Similarity NPC221077
0.9008 High Similarity NPC475169
0.9008 High Similarity NPC105925
0.9008 High Similarity NPC251855
0.9008 High Similarity NPC60885
0.9008 High Similarity NPC105718
0.9008 High Similarity NPC82483
0.9008 High Similarity NPC117214
0.9008 High Similarity NPC233410
0.9008 High Similarity NPC278955
0.9008 High Similarity NPC234400
0.9008 High Similarity NPC203133
0.9008 High Similarity NPC298757
0.9008 High Similarity NPC193544
0.9008 High Similarity NPC17943
0.8993 High Similarity NPC265075
0.8993 High Similarity NPC471389
0.8986 High Similarity NPC260741
0.8986 High Similarity NPC32630
0.8986 High Similarity NPC70682
0.8986 High Similarity NPC55947
0.8986 High Similarity NPC471183
0.8978 High Similarity NPC472334
0.8978 High Similarity NPC472336
0.8978 High Similarity NPC234952
0.8978 High Similarity NPC162659
0.8978 High Similarity NPC173660
0.8978 High Similarity NPC248727
0.8978 High Similarity NPC265433
0.8978 High Similarity NPC270456
0.8971 High Similarity NPC106215
0.8963 High Similarity NPC127624
0.8963 High Similarity NPC86655
0.8963 High Similarity NPC202762
0.8955 High Similarity NPC214860
0.8947 High Similarity NPC23012
0.8944 High Similarity NPC233980
0.8939 High Similarity NPC112596
0.8939 High Similarity NPC76451
0.8936 High Similarity NPC469795

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC212942 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8881 High Similarity NPD3027 Phase 3
0.8667 High Similarity NPD1529 Clinical (unspecified phase)
0.8593 High Similarity NPD1530 Clinical (unspecified phase)
0.8551 High Similarity NPD1613 Approved
0.8551 High Similarity NPD1612 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD4625 Phase 3
0.8143 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8129 Intermediate Similarity NPD4908 Phase 1
0.8129 Intermediate Similarity NPD6234 Discontinued
0.8089 Intermediate Similarity NPD6232 Discontinued
0.8058 Intermediate Similarity NPD3018 Phase 2
0.8039 Intermediate Similarity NPD37 Approved
0.8028 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.8028 Intermediate Similarity NPD3620 Phase 2
0.7987 Intermediate Similarity NPD2801 Approved
0.795 Intermediate Similarity NPD5844 Phase 1
0.7937 Intermediate Similarity NPD7473 Discontinued
0.7899 Intermediate Similarity NPD2983 Phase 2
0.7899 Intermediate Similarity NPD2982 Phase 2
0.7885 Intermediate Similarity NPD4967 Phase 2
0.7885 Intermediate Similarity NPD4965 Approved
0.7885 Intermediate Similarity NPD4966 Approved
0.7883 Intermediate Similarity NPD1610 Phase 2
0.7879 Intermediate Similarity NPD5283 Phase 1
0.7863 Intermediate Similarity NPD228 Approved
0.7826 Intermediate Similarity NPD2981 Phase 2
0.7806 Intermediate Similarity NPD1934 Approved
0.7801 Intermediate Similarity NPD2861 Phase 2
0.7778 Intermediate Similarity NPD7228 Approved
0.777 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.777 Intermediate Similarity NPD4749 Approved
0.7756 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7721 Intermediate Similarity NPD1548 Phase 1
0.7718 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD6674 Discontinued
0.7662 Intermediate Similarity NPD1653 Approved
0.7655 Intermediate Similarity NPD4060 Phase 1
0.7647 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7643 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD7199 Phase 2
0.7576 Intermediate Similarity NPD3021 Approved
0.7576 Intermediate Similarity NPD3022 Approved
0.7547 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD6166 Phase 2
0.7532 Intermediate Similarity NPD1465 Phase 2
0.7516 Intermediate Similarity NPD1511 Approved
0.75 Intermediate Similarity NPD3705 Approved
0.75 Intermediate Similarity NPD4005 Discontinued
0.7485 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7467 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7467 Intermediate Similarity NPD3540 Phase 1
0.7465 Intermediate Similarity NPD6696 Suspended
0.7438 Intermediate Similarity NPD3882 Suspended
0.7432 Intermediate Similarity NPD4097 Suspended
0.7419 Intermediate Similarity NPD1512 Approved
0.7407 Intermediate Similarity NPD7635 Approved
0.74 Intermediate Similarity NPD3539 Phase 1
0.7391 Intermediate Similarity NPD4055 Discovery
0.7386 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD6671 Approved
0.7357 Intermediate Similarity NPD4626 Approved
0.7353 Intermediate Similarity NPD8053 Approved
0.7353 Intermediate Similarity NPD8054 Approved
0.7313 Intermediate Similarity NPD4750 Phase 3
0.7301 Intermediate Similarity NPD5494 Approved
0.7297 Intermediate Similarity NPD1558 Phase 1
0.7292 Intermediate Similarity NPD3094 Phase 2
0.7285 Intermediate Similarity NPD6099 Approved
0.7285 Intermediate Similarity NPD2935 Discontinued
0.7285 Intermediate Similarity NPD6100 Approved
0.7283 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7240 Approved
0.7267 Intermediate Similarity NPD3817 Phase 2
0.7262 Intermediate Similarity NPD7074 Phase 3
0.7256 Intermediate Similarity NPD6959 Discontinued
0.7254 Intermediate Similarity NPD1611 Approved
0.7251 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD5735 Approved
0.7248 Intermediate Similarity NPD3657 Discovery
0.7246 Intermediate Similarity NPD3818 Discontinued
0.7244 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD4624 Approved
0.7235 Intermediate Similarity NPD7549 Discontinued
0.7233 Intermediate Similarity NPD4380 Phase 2
0.7226 Intermediate Similarity NPD7124 Phase 2
0.7225 Intermediate Similarity NPD7906 Approved
0.7222 Intermediate Similarity NPD8651 Approved
0.7209 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD3750 Approved
0.7202 Intermediate Similarity NPD7054 Approved
0.7197 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD4357 Discontinued
0.7179 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD940 Approved
0.7176 Intermediate Similarity NPD846 Approved
0.7168 Intermediate Similarity NPD4663 Approved
0.7164 Intermediate Similarity NPD2342 Discontinued
0.7163 Intermediate Similarity NPD1651 Approved
0.7162 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD5109 Approved
0.7162 Intermediate Similarity NPD5111 Phase 2
0.7162 Intermediate Similarity NPD5110 Phase 2
0.716 Intermediate Similarity NPD7472 Approved
0.7152 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5536 Phase 2
0.7143 Intermediate Similarity NPD5177 Phase 3
0.7135 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD7447 Phase 1
0.7133 Intermediate Similarity NPD3092 Approved
0.7133 Intermediate Similarity NPD422 Phase 1
0.7125 Intermediate Similarity NPD4678 Approved
0.7125 Intermediate Similarity NPD4675 Approved
0.7124 Intermediate Similarity NPD7266 Discontinued
0.7124 Intermediate Similarity NPD5763 Approved
0.7124 Intermediate Similarity NPD5762 Approved
0.7108 Intermediate Similarity NPD7229 Phase 3
0.7108 Intermediate Similarity NPD3787 Discontinued
0.7105 Intermediate Similarity NPD1510 Phase 2
0.7103 Intermediate Similarity NPD1283 Approved
0.7101 Intermediate Similarity NPD1398 Phase 1
0.7099 Intermediate Similarity NPD1242 Phase 1
0.7099 Intermediate Similarity NPD7819 Suspended
0.7099 Intermediate Similarity NPD5929 Approved
0.7097 Intermediate Similarity NPD3892 Phase 2
0.7097 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD7095 Approved
0.7093 Intermediate Similarity NPD4577 Approved
0.7093 Intermediate Similarity NPD4578 Approved
0.7086 Intermediate Similarity NPD1607 Approved
0.7081 Intermediate Similarity NPD5090 Approved
0.7081 Intermediate Similarity NPD5089 Approved
0.7078 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD7340 Approved
0.707 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD7213 Phase 3
0.707 Intermediate Similarity NPD7212 Phase 2
0.707 Intermediate Similarity NPD7041 Phase 2
0.7067 Intermediate Similarity NPD2238 Phase 2
0.7067 Intermediate Similarity NPD1240 Approved
0.7051 Intermediate Similarity NPD2677 Approved
0.7051 Intermediate Similarity NPD6190 Approved
0.7051 Intermediate Similarity NPD2219 Phase 1
0.7051 Intermediate Similarity NPD5241 Discontinued
0.7042 Intermediate Similarity NPD5691 Approved
0.7039 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD4536 Approved
0.7039 Intermediate Similarity NPD4538 Approved
0.7039 Intermediate Similarity NPD6111 Discontinued
0.7034 Intermediate Similarity NPD5327 Phase 3
0.7034 Intermediate Similarity NPD1669 Approved
0.7032 Intermediate Similarity NPD3060 Approved
0.7025 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD2532 Approved
0.7025 Intermediate Similarity NPD2533 Approved
0.7025 Intermediate Similarity NPD2534 Approved
0.7024 Intermediate Similarity NPD27 Approved
0.7024 Intermediate Similarity NPD2489 Approved
0.7018 Intermediate Similarity NPD6797 Phase 2
0.7018 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD1091 Approved
0.7012 Intermediate Similarity NPD7768 Phase 2
0.7007 Intermediate Similarity NPD6584 Phase 3
0.7006 Intermediate Similarity NPD3051 Approved
0.7 Intermediate Similarity NPD2674 Phase 3
0.7 Intermediate Similarity NPD7157 Approved
0.7 Intermediate Similarity NPD709 Approved
0.7 Intermediate Similarity NPD6233 Phase 2
0.6994 Remote Similarity NPD7312 Approved
0.6994 Remote Similarity NPD7313 Approved
0.6994 Remote Similarity NPD7310 Approved
0.6994 Remote Similarity NPD7311 Approved
0.6985 Remote Similarity NPD2684 Approved
0.6977 Remote Similarity NPD6559 Discontinued
0.6977 Remote Similarity NPD7251 Discontinued
0.6972 Remote Similarity NPD3091 Approved
0.697 Remote Similarity NPD7075 Discontinued
0.6966 Remote Similarity NPD2232 Approved
0.6966 Remote Similarity NPD2230 Approved
0.6966 Remote Similarity NPD2233 Approved
0.6964 Remote Similarity NPD2970 Approved
0.6964 Remote Similarity NPD2969 Approved
0.6963 Remote Similarity NPD968 Approved
0.6962 Remote Similarity NPD7390 Discontinued
0.6961 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6957 Remote Similarity NPD7261 Clinical (unspecified phase)
0.6954 Remote Similarity NPD7309 Approved
0.6954 Remote Similarity NPD4140 Approved
0.6954 Remote Similarity NPD943 Approved
0.6951 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6943 Remote Similarity NPD5084 Clinical (unspecified phase)
0.6941 Remote Similarity NPD8252 Approved
0.6941 Remote Similarity NPD8251 Approved
0.6941 Remote Similarity NPD3751 Discontinued
0.6941 Remote Similarity NPD8099 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data